Liposomal Irinotecan Improves Upon 5-FU/LV in Refractory Pancreatic Cancer
Adding liposomal irinotecan to 5-fluorouracil and leucovorin can improve outcomes in gemcitabine-refractory, advanced pancreatic cancer, a phase 3 study suggests.
All articles by Andrea S. Blevins Primeau, PhD, MBA
Real-World Data Suggest Tisagenlecleucel Is Effective in Infant B-ALL
Researchers sought to determine whether tisagenlecleucel was effective would be effective in infant patients with B-ALL
MRI-Based Assessment May Eliminate Need for TURBT in Muscle-Invasive Bladder Cancer
MRI-based assessment shortened the time to correct treatment, when compared with TURBT, for patients with MIBC.
Adding Pembrolizumab to CRT Does Not Improve Outcomes in Head and Neck Cancer
Adding pembrolizumab to chemoradiotherapy did not improve event-free survival or overall survival.
Longer Course of ADT With Postop Radiotherapy Improves Metastasis-Free Survival in Prostate Cancer
Adding a longer course of androgen deprivation therapy to postoperative radiotherapy may prolong metastasis-free survival in patients with prostate cancer.
COSMIC-313: Triplet Prolongs PFS vs Doublet in Renal Cell Carcinoma
The PFS benefit was driven primarily by patients with intermediate-risk disease.
CT-Based Follow-Up Approach May Be Beneficial After NSCLC Resection
A CT-based follow-up approach improved early detection of lung cancer recurrence and second primary lung cancers but did not improve survival.
Frozen-Thawed Embryo Transfer Linked to Increased Risk of Childhood Cancer
A large study suggests that frozen-thawed embryo transfer is associated with an increased risk of childhood cancer, but researchers say these results should be interpreted with caution.
Lower Risk of Smoldering Multiple Myeloma Progression Among African Americans
Researchers sought to determine whether there were differences in rates of progression of smoldering multiple myeloma in African American patients.
Thyroid Cancer Often Detected in Asymptomatic Patients
Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.
- Loading...
Loading...
Next post in Head and Neck Cancer
Loading... 
Loading...